The 10th International Conference on Typhoid and Other Invasive Salmonelloses was held in Kampala, Uganda, on April 4-6, 2017. More than 300 researchers and experts gathered to exchange the latest findings and research on typhoid, paratyphoid and invasive nontyphoidal Salmonella disease. The presentations have been gathered here as a resource.
Program
10th International Conference on Typhoid and Other Invasive Salmonelloses
Attendee List
The list of the more than 300 registrants for the conference can be found here.
Press Release and Recap
The press release after the conference highlighted the important findings and topics of discussion. The recap blog went over the proceedings and explained the significance of the conference.
Video
The sessions were recorded and can watched here. Please note that some of the presentations have been excluded at the request of the presenter.
Photo Gallery
Photos from all three days of the conference can be found here.
News Clips
The 10th International Conference on Typhoid and Other Invasive Salmonelloses garnered news coverage from local and regional media outlets. Read the news stories bringing attention to the burden of typhoid.
Presentations
April 4
Looking to the Future: Control of Typhoid in the Next Decade
Anita Zaidi, Bill & Melinda Gates Foundation
Progress in Typhoid Fever Epidemiology
John Crump, University of Otago
Cal MacLennan on behalf of the MAL055 RTS,S-AS01 Salmonella Ancillary Study
Enteric Fever Among Outbreaks in Africa: Same Old Foe but Emerging New Challenges in Management
Sam Kariuki, Kenya Medical Research Institute
Clades of Salmonella Associated with Epidemics of Invasive Salmonella Disease
Nick Feasey, Liverpool School of Tropical Medicine
Stephane Pouzol, Fondation Mérieux
Identification of a New Serodiagnostic Signature of Acute Typhoid Fever Using Salmonella Proteome Arrays
Thomas Darton, University of Oxford
Antigen Discovery for Improved Diagnosis of Invasive Salmonellosis by Targeted Proteomics
Sara Saleh, Institute of Tropical Medicine, Antwerp
Carriage of Salmonella Typhi Among Vendors in Two Kampala Markets
Mark Bumano, Makerere University College of Health Sciences
Steven Ndugwa Kabwama, Uganda Public Health Fellowship Program
John Lusingu, National Institute for Medical Research
Typhoid Fever in Santiago, Chile: Modern Insights Where Historical Data Meet Mathematical Modeling
Jillian Gauld, Institute for Disease Modeling
Andrew Pollard, University of Oxford
Vinita Vishwanarayan, Clinton Health Access Initiative
Nathan Lo, Stanford University
Development of New Generation Monovalent Typhoid Conjugate Vaccine: Vi-CRM197
Akshay Goel, Biological E
Rezwanul Wahid, University of Maryland School of Medicine
Mark Rudolph, University of Maryland School of Medicine
Zoe Dyson, University of Melbourne
Epidemiology and Disease Burden of Typhoid Fever and iNTS Disease in Sub-Saharan Africa
Florian Marks, International Vaccine Institute
The Severe Typhoid Fever Surveillance in Africa (SETA) Program: An Overview
Justin Im, International Vaccine Institute
SETA: The First Data from the Six African Sites
Se Eun Park, International Vaccine Institute
African Risk Factor Prediction Model and Implications for Vaccination Strategies
Jong-Hoon Kim, International Vaccine Institute
At a Glance: The Surveillance for Enteric Fever in Asia Project (SEAP)
Denise Garrett, Coalition against Typhoid, Sabin Vaccine Institute
Approaches to Community Surveys for Typhoid Burden Estimation: Experience from SEAP
Alexander Yu, Stanford University
Salmonella Typhi and Paratyphi in Bangladesh and Their Antimicrobial Resistance
Samir Saha, Child Health Research Foundation
Looking Back While Moving Forward with Enteric Fever Surveillance in Pakistan
Farah Qamar, Aga Khan University
A Retrospective Review of Existing Hospital-Based Data on Enteric Fever in India
Dipika Sur, Translational Health Science and Technology Institute
April 5
Development and Challenges in Developing a Sensitive Diagnostic Test for Typhoid Fever
Firdausi Qadri, International Centre for Diarrhoeal Disease and Research, Bangladesh
Vaccine and non-Vaccine Measures for Prevention and Control of Typhoid Fever
Eric Mintz, Centers for Disease Control and Prevention
Gaps in Knowledge in Therapeutics and Treatment
Chris Parry, Liverpool School of Tropical Medicine
The SaniPath Approach to Fecal Exposure Assessment and Application to Typhoid Transmission
Christine Moe, Emory University
A Broad-Spectrum Vaccine to Prevent Invasive Salmonella Disease in Sub-Saharan Africa
Myron Levine, University of Maryland School of Medicine
Rajni Gaind, Vardhman Mahavir Medical College & Safdarjung Hospital
Pietro Mastroeni, University of Cambridge
Bhaskar Shenoy, Manipal Hospital, Bangalore, India
Health Outcomes from Multidrug-Resistant Salmonella in High-Income Countries: A Systematic Review
Andrea Parisi, The Australian National University
Multidrug Resistant Non-Typhoidal Salmonella Hotspots as Targets for Vaccine Use in Management
Sam Kariuki, Kenya Medical Research Institute
Satheesh Nair, Public Health England
Emergence of a New Salmonella Typhimurium ST313 Lineage in D.R. Congo with Increased Antibiotic Resistance and Indications for Further Host Adaptation
Sandra Van Puyvelde, Institute of Tropical Medicine Antwerp
Ondari D. Mogeni, International Vaccine Institute
Ravi P.N. Mishra, Biological E
Gianluca Breghi, Fondazione Achille Sclavo
Oliver Koeberling, GSK Vaccines Institute for Global Health
Raphael Simon, University of Maryland School of Medicine
Farhana Khanam, International Centre for Diarrhoeal Disease and Research, Bangladesh
Enusa Ramani, International Vaccine Institute
Salmonella Challenge Studies: Introduction and Historical Perspective
Andrew Pollard, University of Oxford
Assessment of the Efficacy of a Vi-Tetanus Toxoid Conjugate Vaccine Using a Controlled Human Infection Model of Salmonella Typhi
Celina Jin, University of Oxford
Investigating Immunity to Typhoid and Paratyphoid Fever — The Response to Re-Challenge in a Controlled Human Infection Model
Malick Gibani, University of Oxford
Identifying Correlates of Protection — Systemic Immune Responses to Salmonella Typhi and Paratyphi A Infection
Giorgio Napolitani, University of Oxford
Mucosal Immune Responses to Salmonella Typhi and Paratyphi A Infection
Lorena Preciado-Llanes, University of Oxford
Comparative Analysis of Molecular Immune Profiles and Disease Pathogenesis in Typhoid and Paratyphoid Fever
Christoph Blohmke, University of Oxford & Jennifer Hill, University of Oxford
Marcelo Sztein, University of Maryland School of Medicine
Towards Human Challenge with NTS
Cal MacLennan, University of Oxford
April 6
Overview on Vaccine Pipeline: Current Status and Future Plans
Sushant Sahastrabuddhe, International Vaccine Institute
Introduction of Typhoid Conjugate Vaccines: Opportunities and Challenges
Kathy Neuzil, University of Maryland School of Medicine
Development of a Bivalent Salmonella Typhi and Paratyphi A MAPS Vaccine
Rick Malley, Boston Children’s Hospital/Harvard Medical School
Cost-Effectiveness of Typhoid Conjugate Vaccine Strategies Across Five Settings in Africa and Asia
Virginia Pitzer, Yale School of Public Health
TYPBAR TCV®: A Clinical Development Review
Krishna Mohan, Bharat Biotech
Short Overview and Provenance of the Study
Zulfiqar Bhutta, Aga Khan University
Global Review and Epidemiology
Daina Als, SickKids Centre for Global Child Health
Additional Trend Data from Global Burden of Disease Study
Jeff Stanaway, Institute for Health Metrics and Evaluation
Country Case Study: Chile
Catterina Ferreccio, Escuela de Medicina Pontificia Universidad Católica de Chile
Country Case Study: Pakistan
Jai K. Das, Aga Khan University
Country Case Study: Thailand
Amruta Radhakrishnan, The Hospital for Sick Children
Country Case Study: Nigeria
Kabiru Olusegun Akinyemi, Lagos State University
Virulence of Invasive Salmonella Typhimurium ST313 in Animal Infection Models
Ellen Higginson, University of Maryland School of Medicine
Average Treatment Cost for Typhoid Fever and Average Vaccine Delivery Cost per Dose for Each of the 54 GAVI-Eligible Countries
Joke Bilcke, University of Antwerp
Tahir Yousufzai, Aga Khan University
Salmonella enterica Serovars Isolated from Stool of Children Enrolled in the Global Enteric Multicenter Study in Africa
Irene Kasumba, University of Maryland School of Medicine
Senjuti Saha, Child Health Research Foundation
Melita Gordon, University of Liverpool
Kudzai Masunda, City of Harare Health Department
Vittal Mogasale, International Vaccine Institute
Global Typhoid Control in the Context of the Sustainable Development Goals: Pragmatism or Utopia?
Zulfiqar Bhutta, Aga Khan University
Considerations for Revised Global Typhoid Vaccination Policy and Strategies
Adwoa Bentsi-Enchill, World Health Organization
Breaking Good: Making Science Great Again
Robert Breiman, Emory University
Bruce Gellin, Sabin Vaccine Institute
